← SynDRA
TAK-733
SynDRA canonical compound SYN0025693 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MAP2K1 |
|---|
| Mechanism of action | MEK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MEK inhibitor
- MAP2K1 INHIBITOR
- Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
- MAP2K2 INHIBITOR
- Dual specificity mitogen-activated protein kinase kinase 2 inhibitor
Cross-references
Synonyms
- Mek inhibitor tak-733
- Rec-4881
- TAK733
- TAK 733
- UNII-5J61HSP0QJ
- (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione
- 5J61HSP0QJ
- CHEMBL1615025
- 3-[(2r)-2,3-Dihydroxypropyl]-6-Fluoro-5-[(2-Fluoro-4-Iodophenyl)amino]-8-Methylpyrido[2,3-D]pyrimidine-4,7(3h,8h)-Dione
- MLS006011054
- SCHEMBL1528606
- GTPL9911
- DTXSID20648089
- MolPort-023-293-497
- RCLQNICOARASSR-SECBINFHSA-N
- example 18 [US8470837]
- AOB87182
- EX-A2164
- BCP06625
- REC 4881
- RefChem:187199
- MEK Inhibitor REC-4881
- REC4881
- MFCD24386349
- orb1300550
- C17H15F2IN4O4
- SCHEMBL29363215
- TAK 733 [WHO-DD]
- CHEBI:231366
- GLXC-90294
- TAK-733?
- BDBM50337926
- NSC761215
- NSC800940
- s2617
- AKOS027251050
- CCG-264969
- CS-1283
Look up TAK-733 in the interactive SynDRA portal →